• Home
  • Search Results

Search Results

Young Adult (18-34)
Cancer
365 studies match your search
Coming Soon

PRevention Of Frailty with Fisetin (PROFFi) in Breast Cancer Survivors

The purpose of this research study is to examine the effectiveness of the nutritional supplement, fisetin, in improving physical function in women treated for breast cancer.

Age & Gender
  • 18 years ~ 70 years
  • Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Not currently enrolling

Clinical Study of Ivonescimab for First-line Treatment of Metastatic Squamous NSCLC Patients

To determine the overall survival rate of patients with non small cell lung cancer when treated with Ivonescimab.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Lung)
Open

Myeloma Diagnosis Study

Are you an adult diagnosed with multiple myeloma within the last 5 years? If so, you may be able to participate in our research study to help improve how myeloma is diagnosed. Tell us about your experience, what went well, and what didn't, so we can make things better for future myeloma patients. Your voice matters! Compensation will be provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Multiple Myeloma)
  • Minority Health
Visit Location
100% Remote (online, phone, text)
Coming Soon

Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR

To evaluate the safety, optimum drug usage, and anti tumor activity for the drug BDTX-1535.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Lung)
Open

Physical Activity Treatment Study

Do you identify as Black or African-American? Have you been diagnosed with colon cancer, rectal cancer, or colorectal cancer? If so, you may be able to take part in a study to see if an exercise program can help with cancer side effects and overall quality of life. Compensation provided,

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Colorectal)
  • Wellness and Lifestyle
  • Movement
Visit Location
100% Remote (online, phone, text)
Coming Soon

IDH-Wildtype Glioblastoma Treatment Study

In this study, we will find out if a new experimental pill called ropidoxuridine can help improve the treatment of a brain cancer called IDH-Wildtype Glioblastoma. We want to see how well it works when used with radiation therapy.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Brain and Other Nervous System)
Coming Soon

Advanced Melanoma Treatment Study

In this study, we want to find a better treatment for advanced melanoma. We want to see how well two different drugs work compared to the regular treatment.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Melanoma)
Coming Soon

Rehabilitation outcomes study

The purpose of this research study is to improve cancer care for patients whose treatment outcomes have led to challenges in their quality of life. The study is randomized into 2 groups. Group 1 will receive a pre-rehabilitation referral in addition to their standard of care cancer treatment and Group 2 will resume their standard of care cancer treatment. Regardless of the group you are assigned to, all participants will answer questionnaires at baseline and at their 3-month follow-up.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Brain and Other Nervous System, Breast, and 19 more)
Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial), Ovarian)
Coming Soon
Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Kidney)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research